BioLineRx (NASDAQ:BLRX) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of BioLineRx (NASDAQ:BLRX – Free Report) in a report issued on Friday. The firm issued a sell rating on the biotechnology company’s stock. Several other analysts also recently issued reports on the company. HC Wainwright boosted their price objective on BioLineRx from $9.00 to $26.00 and gave the stock a […]
StockNews.com initiated coverage on shares of BioLineRx (NASDAQ:BLRX – Free Report) in a report issued on Friday. The firm issued a sell rating on the biotechnology company’s stock. Several other analysts also recently issued reports on the company. HC Wainwright boosted their price objective on BioLineRx from $9.00 to $26.00 and gave the stock a […]
